Literature DB >> 27476667

Antiplatelet Drugs and Endothelial Function.

Yukihito Higashi1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27476667      PMCID： PMC5098914          DOI： 10.5551/jat.ED054

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  10 in total

1.  Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease.

Authors:  V Schächinger; M B Britten; A M Zeiher
Journal:  Circulation       Date:  2000-04-25       Impact factor: 29.690

2.  Comparison of the effect of cilostazol with aspirin on circulating endothelial progenitor cells and small-dense LDL cholesterol in diabetic patients with cerebral ischemia: a randomized controlled pilot trial.

Authors:  Hiroki Ueno; Hidenori Koyama; Yohei Mima; Shinya Fukumoto; Shinji Tanaka; Takuhito Shoji; Masanori Emoto; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Journal:  J Atheroscler Thromb       Date:  2011-06-24       Impact factor: 4.928

3.  Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.

Authors:  Sebastian Wolfrum; Andreas Dendorfer; Yoshiyuki Rikitake; Timothy J Stalker; Yulan Gong; Rosario Scalia; Peter Dominiak; James K Liao
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-19       Impact factor: 8.311

4.  Oral sarpogrelate can improve endothelial dysfunction as effectively as oral cilostazol, with fewer headaches, in active young male smokers.

Authors:  Il Soon Jeong; Jae-Hyeong Park; Seon Ah Jin; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  Heart Vessels       Date:  2012-09-12       Impact factor: 2.037

Review 5.  Endothelial function and oxidative stress in cardiovascular diseases.

Authors:  Yukihito Higashi; Kensuke Noma; Masao Yoshizumi; Yasuki Kihara
Journal:  Circ J       Date:  2009-02-04       Impact factor: 2.993

6.  Cilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury model.

Authors:  Rie Kawabe-Yako; Masaaki Ii; Ii Masaaki; Osamu Masuo; Takayuki Asahara; Toru Itakura
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

Review 7.  Comparative Efficacy and Safety of Different Antiplatelet Agents for Prevention of Major Cardiovascular Events and Leg Amputations in Patients with Peripheral Arterial Disease: A Systematic Review and Network Meta-Analysis.

Authors:  Konstantinos Katsanos; Stavros Spiliopoulos; Prakash Saha; Athanasios Diamantopoulos; Narayan Karunanithy; Miltiadis Krokidis; Bijan Modarai; Dimitris Karnabatidis
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

8.  The Effect of Cilostazol on Endothelial Function as Assessed by Flow-Mediated Dilation in Patients with Coronary Artery Disease.

Authors:  Hiroyoshi Mori; Atsuo Maeda; Kohei Wakabayashi; Tokutada Sato; Masahiro Sasai; Kazuma Tashiro; Yoshitaka Iso; Mio Ebato; Hiroshi Suzuki
Journal:  J Atheroscler Thromb       Date:  2016-05-09       Impact factor: 4.928

9.  Levels and values of lipoprotein-associated phospholipase A2, galectin-3, RhoA/ROCK, and endothelial progenitor cells in critical limb ischemia: pharmaco-therapeutic role of cilostazol and clopidogrel combination therapy.

Authors:  Jiunn-Jye Sheu; Pao-Yuan Lin; Pei-Hsun Sung; Yi-Ching Chen; Steve Leu; Yung-Lung Chen; Tzu-Hsien Tsai; Han-Tan Chai; Sarah Chua; Hsueh-Wen Chang; Sheng-Ying Chung; Chih-Hung Chen; Sheung-Fat Ko; Hon-Kan Yip
Journal:  J Transl Med       Date:  2014-04-17       Impact factor: 5.531

10.  Combined therapeutic effect of probucol and cilostazol on endothelial function in patients with silent cerebral lacunar infarcts and hypercholesterolemia: a preliminary study.

Authors:  Bonpei Takase; Masayoshi Nagata; Hidemi Hattori; Yoshihiro Tanaka; Masayuki Ishihara
Journal:  Med Princ Pract       Date:  2013-11-09       Impact factor: 1.927
  10 in total
  1 in total

1.  The Efficacy and Safety of Cilostazol vs. Aspirin for Secondary Stroke Prevention: A Systematic Review and Meta-Analysis.

Authors:  Erqing Chai; Jinhua Chen; Changqing Li; Xue Zhang; Zhiqiang Fan; Shijie Yang; Kaixuan Zhao; Wei Li; Zaixing Xiao; Yichuan Zhang; Futian Tang
Journal:  Front Neurol       Date:  2022-02-15       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.